Treatment of Colonic Diverticulitis in Immunocompromised or Immunosuppressed Patients

Immune suppression fundamentally changes the risk profile of colonic diverticulitis. This clinical scenario requires a distinct management approach that accounts for the heightened risk of severe or complicated disease progression.

Clinical Scenario

Immunocompromised and immunosuppressed patients are more likely to present with severe or complicated diverticulitis. Even those with initially uncomplicated disease are at elevated risk for rapid progression to complicated diverticulitis and sepsis, making prompt and appropriate treatment essential.

Treatment Approach — Partial Overview

Management in this population involves broad-spectrum antibiotic therapy. The complete regimen — including specific agents, required pathogen coverage, and treatment duration — is outlined in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1053/j.gastro.2020.09.059

Immunocompromised patients are more likely to present with severe or complicated disease.
Patients with uncomplicated diverticulitis who are immunosuppressed are at high risk for progression to complicated diverticulitis and/or sepsis and should be treated with antibiotics.
The antibiotic regimen usually includes broad-spectrum agents with gram-negative and anaerobic coverage with a longer duration of treatment (10–14 days).

View source ↗